The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

Home | Video pages | Webcast | Alport syndrome, from childhood to adulthood including transition

Alport syndrome, from childhood to adulthood including transition

Video resources

First video

Second video

*The specific content of these links is part of this specific e-seminar, therefore ERA has no responsibility